𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Stereoselective synthesis of conformationally constrained reverse turn dipeptide mimetics

✍ Scribed by Wei Qiu; Xuyuan Gu; Vadim A Soloshonok; Michael D Carducci; Victor J Hruby


Publisher
Elsevier Science
Year
2001
Tongue
French
Weight
93 KB
Volume
42
Category
Article
ISSN
0040-4039

No coin nor oath required. For personal study only.

✦ Synopsis


Peptide side chains play critical roles in the event of molecular recognition. In order to study the bioactive conformation of parent peptides, a concise and straightforward five-step synthesis of [5.5]-bicyclic reverse turn dipeptide mimetic scaffolds with side chain functionality at the i+1 and i + 2 positions has been developed. In the bicyclic structure, two dihedral angles ( 2 and 3 ) are greatly restricted.


πŸ“œ SIMILAR VOLUMES


ChemInform Abstract: Stereoselective Syn
✍ Wei Qiu; Xuyuan Gu; Vadim A. Soloshonok; Michael D. Carducci; Victor J. Hruby πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons βš– 30 KB πŸ‘ 2 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a β€œFull Text” option. The original article is trackable v

Synthesis of conformationally constraine
✍ Paolo Grieco; Pietro Campiglia; Isabel Gomez-Monterrey; Ettore Novellino πŸ“‚ Article πŸ“… 2002 πŸ› Elsevier Science 🌐 French βš– 89 KB

A dipeptide analog b-turn mimetic with fixed configuration at a-carbons of two amino acid residues in structure type b-turn has been synthesized starting from L-phenilalanine and L-cysteine in short steps.

Synthesis of constrained bicyclic dipept
✍ M.Arshad Siddiqui; Patrice PrΓ©ville; Micheline Tarazi; Scott E. Warder; Paul Eby πŸ“‚ Article πŸ“… 1997 πŸ› Elsevier Science 🌐 French βš– 198 KB

An efficient synthesis of constrained bicyclic peptidomimetics of (R)-Phe-Pro dipeptide is described. Such mimetics may provide an opportunity to develop inhibitors of thrombin possessing the desired pharmacological features.